Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
LFT abnormalities
•
JAK Inhibitors
Would you prescribe a JAK inhibitor in patients with baseline transaminase elevation?
Related Questions
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
Can JAK inhibitors for established rheumatoid arthritis be continued when starting an immune checkpoint inhibitor?
How do you approach monitoring when using combination JAK inhibitors and methotrexate in RA?
How you do approach management of a patient with previously well-controlled RA, who is now having recurrent flares of multiple joints which is resistant to even high dose steroids?
What is your approach for an RA patient with lung cancer who is starting immunotherapy?
Would you continue Jak inhibitor therapy in a patient with long standing, previously refractory RA in their 60s who was found to have stenosis of the left common femoral artery and no other history of arteriosclerotic disease?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What is your approach to the diagnosis of LGL leukemia or Felty's Syndrome in a patient with rheumatoid arthritis?
What is your approach to treating Felty syndrome in a patient with well controlled synovitis on MTX/leflunomide with persistent neutropenia/cytopenias?
Do you offer LDRT for psoriatic arthritis, rheumatoid arthritis, or polymyalgia rheumatica or fibromyalgia?
